ArticleFrontiers in oncology2022

An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma.

Chaohu Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.